Entry |
|
Symbol |
Plcb4
|
Name |
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4
|
KO |
|
Organism |
rno Rattus norvegicus (rat)
|
Pathway |
rno04070 | Phosphatidylinositol signaling system |
rno04072 | Phospholipase D signaling pathway |
rno04261 | Adrenergic signaling in cardiomyocytes |
rno04270 | Vascular smooth muscle contraction |
rno04613 | Neutrophil extracellular trap formation |
rno04621 | NOD-like receptor signaling pathway |
rno04723 | Retrograde endocannabinoid signaling |
rno04750 | Inflammatory mediator regulation of TRP channels |
rno04919 | Thyroid hormone signaling pathway |
rno04925 | Aldosterone synthesis and secretion |
rno04927 | Cortisol synthesis and secretion |
rno04928 | Parathyroid hormone synthesis, secretion and action |
rno04933 | AGE-RAGE signaling pathway in diabetic complications |
rno04935 | Growth hormone synthesis, secretion and action |
rno04961 | Endocrine and other factor-regulated calcium reabsorption |
rno04973 | Carbohydrate digestion and absorption |
rno05022 | Pathways of neurodegeneration - multiple diseases |
rno05163 | Human cytomegalovirus infection |
|
Module |
rno_M00130 | Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4 |
|
Brite |
KEGG Orthology (KO) [BR:rno00001]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
25031 (Plcb4)
09130 Environmental Information Processing
09132 Signal transduction
04015 Rap1 signaling pathway
25031 (Plcb4)
04310 Wnt signaling pathway
25031 (Plcb4)
04371 Apelin signaling pathway
25031 (Plcb4)
04020 Calcium signaling pathway
25031 (Plcb4)
04070 Phosphatidylinositol signaling system
25031 (Plcb4)
04072 Phospholipase D signaling pathway
25031 (Plcb4)
04071 Sphingolipid signaling pathway
25031 (Plcb4)
04022 cGMP-PKG signaling pathway
25031 (Plcb4)
09133 Signaling molecules and interaction
04082 Neuroactive ligand signaling
25031 (Plcb4)
04081 Hormone signaling
25031 (Plcb4)
09140 Cellular Processes
09144 Cellular community - eukaryotes
04540 Gap junction
25031 (Plcb4)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
25031 (Plcb4)
04613 Neutrophil extracellular trap formation
25031 (Plcb4)
04621 NOD-like receptor signaling pathway
25031 (Plcb4)
04062 Chemokine signaling pathway
25031 (Plcb4)
09152 Endocrine system
04911 Insulin secretion
25031 (Plcb4)
04922 Glucagon signaling pathway
25031 (Plcb4)
04929 GnRH secretion
25031 (Plcb4)
04912 GnRH signaling pathway
25031 (Plcb4)
04915 Estrogen signaling pathway
25031 (Plcb4)
04921 Oxytocin signaling pathway
25031 (Plcb4)
04926 Relaxin signaling pathway
25031 (Plcb4)
04935 Growth hormone synthesis, secretion and action
25031 (Plcb4)
04918 Thyroid hormone synthesis
25031 (Plcb4)
04919 Thyroid hormone signaling pathway
25031 (Plcb4)
04928 Parathyroid hormone synthesis, secretion and action
25031 (Plcb4)
04916 Melanogenesis
25031 (Plcb4)
04924 Renin secretion
25031 (Plcb4)
04925 Aldosterone synthesis and secretion
25031 (Plcb4)
04927 Cortisol synthesis and secretion
25031 (Plcb4)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
25031 (Plcb4)
04270 Vascular smooth muscle contraction
25031 (Plcb4)
09154 Digestive system
04970 Salivary secretion
25031 (Plcb4)
04971 Gastric acid secretion
25031 (Plcb4)
04972 Pancreatic secretion
25031 (Plcb4)
04973 Carbohydrate digestion and absorption
25031 (Plcb4)
09155 Excretory system
04961 Endocrine and other factor-regulated calcium reabsorption
25031 (Plcb4)
09156 Nervous system
04724 Glutamatergic synapse
25031 (Plcb4)
04725 Cholinergic synapse
25031 (Plcb4)
04728 Dopaminergic synapse
25031 (Plcb4)
04726 Serotonergic synapse
25031 (Plcb4)
04720 Long-term potentiation
25031 (Plcb4)
04730 Long-term depression
25031 (Plcb4)
04723 Retrograde endocannabinoid signaling
25031 (Plcb4)
09157 Sensory system
04742 Taste transduction
25031 (Plcb4)
04750 Inflammatory mediator regulation of TRP channels
25031 (Plcb4)
09159 Environmental adaptation
04713 Circadian entrainment
25031 (Plcb4)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
25031 (Plcb4)
09172 Infectious disease: viral
05163 Human cytomegalovirus infection
25031 (Plcb4)
09174 Infectious disease: parasitic
05146 Amoebiasis
25031 (Plcb4)
05142 Chagas disease
25031 (Plcb4)
05143 African trypanosomiasis
25031 (Plcb4)
09164 Neurodegenerative disease
05010 Alzheimer disease
25031 (Plcb4)
05016 Huntington disease
25031 (Plcb4)
05017 Spinocerebellar ataxia
25031 (Plcb4)
05022 Pathways of neurodegeneration - multiple diseases
25031 (Plcb4)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
25031 (Plcb4)
05415 Diabetic cardiomyopathy
25031 (Plcb4)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
25031 (Plcb4)
04934 Cushing syndrome
25031 (Plcb4)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:rno04131]
25031 (Plcb4)
Enzymes [BR:rno01000]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
25031 (Plcb4)
Membrane trafficking [BR:rno04131]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
25031 (Plcb4)
Endocytosis
Macropinocytosis
Phospholipase C
25031 (Plcb4)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
3:143405721..143775129
|
AA seq |
1176 aa
MAKPYEFNWQKEVPSFLQEGAVFDRYEEESFVFEPNCLFKVDEFGFFLTWKSEGKEGQVL
ECSLINSIRLAAIPKDPKILAALESVGKSENDLEGRILCVCSGTDLVNIGFTYMVAENPE
ITKQWVEGLRSIIHNFRANNVSPMTCLKKHWMKLAFLTNTSGKIPVRSITRTFASGKTEK
VIFQALKELGLPSGKNDEIEPAAFTYEKFYELTQKICPRTDIEDLFKKINGDKTDYLTVD
QLVSFLNEHQRDPRLNEILFPFYDAKRAMQIIEMYEPDEELKKKGLISSDGFCRYLMSDE
NAPVFLDRLELYQEMDHPLAHYFISSSHNTYLTGRQFGGKSSVEMYRQVLLAGCRCVELD
CWDGKGEDQEPIITHGKAMCTDILFKDVIQAIKETAFVTSEYPVILSFENHCSKYQQYKM
SKYCEDLFGDLLLKQALESHPLEPGRPLPSPNDLKRKILIKNKRLKPEVEKKQLEALKSM
MEAGESAAPASILEDDNEEEIESAADQEEEAHPEYKFGNELSADDFSHKEAVANSVKKGL
VTVEDEQAWMASYKYVGATTNIHPYLSTMINYAQPVKFQGFHVAEERNIHYNMSSFNESV
GLGYLKTHAIEFVNYNKRQMSRIYPKGGRVDSSNYMPQIFWNAGCQMVSLNYQTPDLAMQ
LNQGKFEYNGSCGYLLKPDFMRRPDRTFDPFSETPVDGVIAATCSVQVISGQFLSDKKIG
TYVEVDMYGLPTDTIRKEFRTRMVMNNGLNPVYNEESFVFRKVILPDLAVLRIAVYDDNN
KLIGQRILPLDGLQAGYRHISLRNEGNKPLSLPTIFCNIVLKTYVPDGFGDIVDALSDPK
KFLSITEKRADQMRAMGIETSDIADVPSDTSKNDKKGKANPAKANVTPQSSSELRPTTTA
ALGSGQEAKKGIELIPQVRIEDLKQMKAYLKHLKKQQKELNSLKKKHAKEHSTMQKLHCT
QVDKIVAQYDKEKSTHEKILEKAMKKKGGSNCLEIKKETEIKIQTLTSDHKSKVKEIVAQ
HTKEWSEMINTHSAEEQEIRDLHLSQQCELLRKLLINAHEQQTQQLKLSHDRESKEMRAH
QAKISMENSKAISQDKSIKNKAERERRVRELNSSNTKKFLEERKRLAMKQSKEMDQLKKV
QLEHLEFLEKQNEQAKEMQQMVKLEAEMDRRPATVV |
NT seq |
3531 nt +upstreamnt +downstreamnt
atggccaaaccttacgaatttaactggcagaaggaggtaccctctttcttgcaagaagga
gcagtttttgacagatatgaagaggaatctttcgtgtttgagcccaactgcctcttcaaa
gtggatgaattcggcttcttcctgacctggaagagtgaaggcaaggaaggacaagtgcta
gaatgttccctcatcaacagcattcggctggcagccataccaaaggatcccaaaatcctg
gctgctctcgagtctgttggaaaatctgaaaatgatctggaagggcggatattgtgtgtc
tgcagcggcacggatctggtgaatattggcttcacttacatggtggctgaaaacccagaa
ataactaagcaatgggtagaaggcctgagatcaatcattcacaacttcagggcaaacaac
gtcagtccgatgacatgcctcaagaaacactggatgaaactggcctttctgaccaacaca
agtggcaaaatcccagtgaggagtattactagaaccttcgcatcagggaaaacagaaaag
gtgatctttcaagcactcaaggaattaggtctccccagtggaaagaatgatgaaattgaa
cctgctgcatttacctatgaaaagttctatgaactgacacagaagatttgtcctcggaca
gatatagaagatctttttaaaaaaatcaatggagacaaaactgattatttaacggtagac
caattagtgagctttctaaacgaacatcagcgagatcctcggctgaatgaaattttattc
ccgttttatgatgctaaaagagcaatgcagatcattgagatgtatgaacctgatgaagag
ttgaagaaaaaaggcctcatatccagtgatggattctgcagatatctcatgtcagatgaa
aatgcccccgtcttcctagatcgcttagaactttaccaggagatggaccaccccctggcc
cattacttcatcagttcctctcacaacacctatctcaccggccggcagtttggcggaaag
tcttcagtggaaatgtaccgacaagtcctcctggctggttgcaggtgtgtggaacttgac
tgttgggatggaaaaggtgaagatcaggaaccaataataactcacggaaaagcaatgtgt
acagacatcctttttaaggatgtaatccaggccatcaaggaaacagcgtttgtcacatca
gaatatcctgtaattctctcctttgaaaaccactgcagcaaatatcaacagtacaagatg
tccaagtattgtgaagatctatttggggatctcctgttgaaacaagcacttgagtcacat
ccacttgaaccagggaggcccttgccatctcctaatgacctcaaaagaaaaatactcatc
aaaaataaaaggctgaagcctgaagttgaaaaaaaacagctggaggctttgaaaagcatg
atggaggctggagaatcagctgccccggccagcatcttggaagatgacaatgaggaggaa
atagaaagcgcagctgatcaagaggaagaagcccaccctgaatacaagtttggaaatgaa
ctttctgccgatgacttcagtcacaaggaagcggttgcaaacagcgtcaagaagggcctg
gtcaccgtagaagatgagcaggcatggatggcatcttataaatacgtaggtgctaccacg
aatatccatccgtacttgtccacgatgatcaactatgcacagcctgtgaagtttcaaggt
ttccatgtggctgaagagcgcaacattcattataacatgtcttcttttaacgagtcggtt
ggccttggctacttgaagacgcacgcgattgagtttgtaaattacaataagcgacaaatg
agccgcatttaccccaagggaggccgagttgattccagtaattacatgcctcagattttc
tggaacgctggttgccagatggtttcactgaactatcaaaccccagatttagcgatgcaa
ttgaatcaaggaaaatttgagtataacggatcctgcggatacctcctcaagccagacttc
atgagacggcctgatcggacatttgatcccttctctgaaacccctgtggacggggttatt
gcagccacatgctcagtgcaggttatatcagggcagttcctgtcagataagaagatcggc
acatacgtggaagtcgatatgtacgggctgcccaccgacaccatacggaaggagttccga
acccgcatggttatgaacaatggactcaacccagtttacaatgaagaatcgttcgtgttt
cggaaggtgatcctgcctgacctggctgtcctgagaatcgctgtgtacgacgacaacaac
aagctcattggccagaggatccttcctctggatggcctccaggcaggctaccgacacatc
tccctgagaaatgagggaaacaaaccgttatcactgccaacaattttctgcaatatcgtt
cttaaaacatatgtgcctgatggatttggagatattgtggatgctctatccgatccaaag
aaattcctttcaatcacagagaagagagcagaccaaatgagagcaatgggcattgaaact
agtgacatagcagatgtgcccagtgacacttccaaaaatgacaagaaaggcaaggccaac
ccagccaaagcgaatgtaacccctcagagcagctctgagctcagaccaaccaccacagct
gccctgggctctggccaggaagccaagaaaggtattgaacttatccctcaagtgaggata
gaagatttaaagcaaatgaaggcttacttgaagcatttaaagaaacaacaaaaggagtta
aactctttaaagaagaaacacgcaaaggagcacagtaccatgcagaagttacactgcaca
caagtggacaaaatcgtggcccagtatgacaaggagaagtcgactcatgagaaaatccta
gagaaggccatgaagaagaaggggggaagtaattgccttgaaataaaaaaagaaacagaa
attaagattcagaccctgacatcggatcacaaatctaaggtcaaggagattgtggcgcag
cacacaaaggagtggtcagaaatgatcaacacgcacagcgccgaggagcaggaaatccgg
gacctgcacctgagccagcagtgtgagctgctgaggaagctgctcatcaacgctcatgag
cagcagacccagcagctgaagctctcccatgacagggaaagcaaagagatgcgagcccat
caggctaagatttctatggaaaatagcaaagccatcagtcaagataaatctatcaagaat
aaggcagaacgggagaggcgagtcagggagttgaacagcagcaacactaagaagtttcta
gaagaaagaaagagactggcaatgaagcagtcgaaagaaatggatcagttgaaaaaggtc
cagctggagcacctagaattcctagagaaacagaatgagcaggcgaaggagatgcagcag
atggtgaaattggaagccgagatggaccgcagaccagcaacagtagtatga |